Study guide

11.4 Human Health & Ecological Risk Assessment (HQ, Hazard Index, Cancer Risk)

Certified Hazardous Materials Manager CHMM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Planning and Management of Hazardous Materials

1.1 Hazard Identification & GHS Classification 1.2 Safety Data Sheets (SDS) & Chemical Compatibility 1.3 Life-Cycle Management, Source Reduction & Pollution Prevention 1.4 Chemical Inventory & Regulatory Applicability Framework 1.5 Pollution Prevention Opportunity Assessments (PPOA) & P2 Program Implementation

2 Chapter 2: Shipping and Transporting Hazardous Materials

2.1 DOT HazMat Classification & Table 172.101 2.2 Packaging Standards, Marking, Labeling & UN Specifications 2.3 Shipping Papers, Uniform Hazardous Waste Manifest & e-Manifest 2.4 Placarding Requirements, Exceptions & Modal Transport

3 Chapter 3: Storage of Hazardous Materials

3.1 RCRA Container Storage & Inspection Requirements 3.2 Aboveground (AST) & Underground Storage Tank (UST) Standards 3.3 Secondary Containment Design & Sizing Calculations 3.4 Chemical Segregation, Flammable Liquids & Compressed Gas Storage

4 Chapter 4: Facility Operations & Environmental Permitting

4.1 Process Safety Management (PSM) & Risk Management Plan (RMP) 4.2 Spill Prevention, Control, and Countermeasure (SPCC) & Facility Response Plans 4.3 Clean Air Act: Operating Permits, NESHAP & Emission Controls 4.4 Clean Water Act: NPDES, Industrial Wastewater Pretreatment & SWPPP

5 Chapter 5: Disposition of Hazardous Materials & Waste Management

5.1 RCRA Hazardous Waste Determination: Characteristic & Listed Wastes 5.2 Generator Categories (VSQG, SQG, LQG) & Accumulation Rules 5.3 Satellite Accumulation Areas (SAA) & Universal Waste Management 5.4 Used Oil Management, Land Disposal Restrictions (LDR) & TSDF Operations 5.5 Waste Profiling, Disposal Vendor Qualification & Final Disposition Documentation

6 Chapter 6: Regulatory Recordkeeping & Reporting

6.1 EPCRA Tier II (Section 312) & Toxic Release Inventory (TRI Section 313) 6.2 RCRA Biennial Reporting, Exception Reports & TSCA Reporting 6.3 Regulatory Record Retention Periods & Compliance Documentation

7 Chapter 7: Personnel Training Programs & Competency

7.1 HAZWOPER Training Standards (29 CFR 1910.120) & Emergency Roles 7.2 DOT HazMat (49 CFR 172) & RCRA Generator Training Mandates 7.3 OSHA Hazard Communication Training, Adult Learning & Competency Evaluation

8 Chapter 8: Emergency Response, Incident Command & Recovery

8.1 Emergency Response Planning & Incident Command System (ICS/NIMS) 8.2 Spill Notification: Reportable Quantities (RQ), NRC, SERC & LEPC 8.3 Spill Containment, Mitigation Techniques & Air Monitoring 8.4 Decontamination Procedures, Site Control Zones & Post-Incident Recovery

9 Chapter 9: Environmental Remediation & Site Assessment

9.1 Environmental Site Assessments: ASTM Phase I & Phase II ESA 9.2 CERCLA Superfund Process & RCRA Corrective Action 9.3 In-Situ Remediation Technologies (ISCO, SVE, Bioremediation, PRBs) 9.4 Ex-Situ Remediation Technologies, Risk-Based Corrective Action (RBCA) & CSM

10 Chapter 10: Environmental Management Systems & Compliance Auditing

10.1 ISO 14001:2015 Environmental Management Systems (EMS) & PDCA 10.2 Environmental Auditing Protocols & EPA Audit Policy (Self-Disclosure) 10.3 Root Cause Analysis, CAPA Systems & IHMM Code of Ethics 10.4 Regulatory Currency, Rulemaking Participation, Public Outreach & Environmental Cost Analysis

11 Chapter 11: Environmental Fate, Hydrogeology & Sampling

11.1 Chemical Fate and Transport Mechanisms (Partitioning, Darcy's Law, Advection) 11.2 Soil, Groundwater & Air Sampling Protocols and Chain of Custody 11.3 Data Quality Objectives (DQOs), Analytical Methods & PARCC Parameters 11.4 Human Health & Ecological Risk Assessment (HQ, Hazard Index, Cancer Risk)

12 Chapter 12: Occupational Health, Industrial Hygiene & Safety

12.1 Industrial Hygiene Principles (AREC) & Occupational Exposure Limits (PEL, TLV, REL, IDLH) 12.2 Chemical Toxicology, Routes of Entry & Dose-Response (LD50, LC50) 12.3 Hierarchy of Controls & Engineering Solutions 12.4 Personal Protective Equipment (Levels A-D) & Respiratory Protection Programs (APF, MUC) 12.5 Industrial Hygiene Monitoring Equipment (PID, FID, Multi-Gas Meters, Noise & Heat Stress) 12.6 Job Hazard Analysis (JHA), the HAZWOPER Site Safety and Health Plan (HASP) & Required Written Programs

11.4 Human Health & Ecological Risk Assessment (HQ, Hazard Index, Cancer Risk)

Key Takeaways Explain This Topic AI

The EPA Risk Assessment Guidance for Superfund (RAGS Part A) establishes the standard 4-step human health risk paradigm: Hazard Identification, Dose-Response Assessment, Exposure Assessment, and Risk Characterization.

Noncancer risk is screened with HQ = CDI/RfD and target-organ Hazard Indices. HQ or HI above 1 means the reference level is exceeded and effects cannot be ruled out; it is not proof of harm or an automatic remedial-action threshold.

Cancer risk is estimated as ELCR = CDI × CSF. Under the NCP, EPA generally manages Superfund risks within the 10^-6 to 10^-4 target range and uses 10^-6 as the point of departure; a value inside or outside that range informs, but does not alone decide, the remedy.

Chronic Daily Intake ( C D I = C ⋅ I R ⋅ E F ⋅ E D B W ⋅ A T CDI = \frac{C \cdot IR \cdot EF \cdot ED}{BW \cdot AT} C D I = B W ⋅ A T C ⋅ I R ⋅ EF ⋅ E D ​ ) differentiates non-carcinogens ( A T = E D ⋅ 365 days AT = ED \cdot 365\text{ days} A T = E D ⋅ 365 days ) from carcinogens ( A T = 70 years ⋅ 365 days = 25 , 550 days AT = 70\text{ years} \cdot 365\text{ days} = 25,550\text{ days} A T = 70 years ⋅ 365 days = 25 , 550 days ).

Ecological screening compares an estimated environmental concentration with a toxicity reference value. EHQ above 1 means ecological risk cannot be ruled out and supports refinement or BERA; EHQ at or below 1 is a screening result, not proof of zero risk.

Last updated: August 2026

Human Health & Ecological Risk Assessment (HQ, Hazard Index, Cancer Risk)

Risk assessment is the scientific process of evaluating the likelihood that adverse ecological or human health effects may occur as a result of exposure to one or more hazardous chemical substances. Under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) and the Resource Conservation and Recovery Act (RCRA) , risk assessment provides the quantitative basis for establishing site cleanup levels, selecting engineering remedies, and justifying "No Further Action" determinations.

The United States Environmental Protection Agency (EPA) formalizes risk assessment through two landmark guidance frameworks:

EPA Risk Assessment Guidance for Superfund (RAGS), Volume I: Human Health Evaluation Manual (Part A) (EPA/540/1-89/002).

Ecological Risk Assessment Guidance for Superfund (ERAGS): Process for Designing and Conducting Ecological Risk Assessments (EPA 540-R-97-006).

1. The 4-Step Human Health Risk Assessment Paradigm +-----------------------------------------------------------------------------------------+

  • | THE EPA 4-STEP RISK ASSESSMENT PARADIGM |
  • | |
  • | [STEP 1] HAZARD IDENTIFICATION |
  • | - Screen Chemicals of Potential Concern (COPCs), identify target organs & endpoints. |
  • | | |
  • | v |
  • | [STEP 2] DOSE-RESPONSE ASSESSMENT |
  • | - Non-Carcinogens: Reference Dose (RfD, mg/kg-day) & Reference Conc (RfC, mg/m^3) |
  • | - Carcinogens: Cancer Slope Factor [CSF, (mg/kg-day)^-1] & Inhalation Unit Risk (IUR) |
  • | | |
  • | v |
  • | [STEP 3] EXPOSURE ASSESSMENT |
  • | - Delineate Conceptual Site Model (CSM) pathways, receptors, and intake rates. |
  • | - Calculate Chronic Daily Intake: CDI = (C * IR * EF * ED) / (BW * AT) |
  • | | |
  • | v |
  • | [STEP 4] RISK CHARACTERIZATION |
  • | - Non-Cancer Risk: Hazard Quotient (HQ = CDI / RfD) & Hazard Index (HI = SUM HQi) |
  • | - Cancer Risk: Excess Lifetime Cancer Risk (ELCR = CDI * CSF) |
  • | - Compare to Superfund benchmarks: HI <= 1.0 and ELCR within 10^-6 to 10^-4 |
  • +-----------------------------------------------------------------------------------------+
  • Step 1: Hazard Identification

Identifies the Chemicals of Potential Concern (COPCs) present in environmental media (soil, groundwater, surface water, sediment, air) by comparing site maximum concentrations against background levels and EPA Regional Screening Levels (RSLs). Toxicological profiles are reviewed to identify adverse toxic endpoints (e.g., hepatotoxicity, nephrotoxicity, neurotoxicity, developmental toxicity, carcinogenicity).

Step 2: Dose-Response Assessment

Establishes the quantitative mathematical relationship between the administered dose of a chemical and the incidence or severity of adverse biological effects in exposed populations:

1. Non-Carcinogenic Toxicity (Threshold Model)

Non-carcinogens operate under a biological threshold: homeostatic repair mechanisms protect the body until a threshold dose is exceeded.

NOAEL (No Observed Adverse Effect Level): The highest experimental exposure level at which there is no statistically or biologically significant increase in frequency or severity of adverse effects.

LOAEL (Lowest Observed Adverse Effect Level): The lowest exposure level at which adverse effects are observed.

Reference Dose ( R f D RfD R f D , mg/kg-day \text{mg/kg-day} mg/kg-day ): An estimate of daily oral exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime: R f D = NOAEL (or LOAEL) ∏ UF × MF RfD = \frac{\text{NOAEL (or LOAEL)}}{\prod \text{UF} \times \text{MF}} R f D = ∏ UF × MF NOAEL (or LOAEL) ​ Where Uncertainty Factors (UFs) account for scientific uncertainties (each typically 10 × 10\times 10 × or 3 × 3\times 3 × ):

  • U F A UF_A U F A ​ : Animal-to-human interspecies extrapolation ( 10 × 10\times 10 × )
  • U F H UF_H U F H ​ : Intraspecies human sensitivity variation ( 10 × 10\times 10 × )
  • U F S UF_S U F S ​ : Subchronic-to-chronic exposure duration extrapolation ( 10 × 10\times 10 × )
  • U F L UF_L U F L ​ : LOAEL-to-NOAEL extrapolation if NOAEL is unavailable ( 10 × 10\times 10 × )
  • U F D UF_D U F D ​ : Incomplete toxicological database deficiency ( 10 × 10\times 10 × )

M F MF MF : Modifying Factor based on professional judgment ( 0.1 to 10 0.1\text{ to }10 0.1 to 10 , default = 1.0 = 1.0 = 1.0 )

Reference Concentration ( R f C RfC R f C , mg/m 3 \text{mg/m}^3 mg/m 3 ): Equivalent benchmark for continuous inhalation exposure.

2. Carcinogenic Toxicity (Non-Threshold Linear Multistage Model)

EPA assumes that for genotoxic carcinogens, there is no absolute threshold dose ; any non-zero exposure confers some theoretical probability of initiating DNA damage leading to carcinogenesis.

Cancer Slope Factor ( C S F CSF CSF or q 1 ∗ q_1^* q 1 ∗ ​ , expressed in ( mg/kg-day ) − 1 (\mathbf{\text{mg/kg-day})^{-1}} ( mg/kg-day ) − 1 ): The upper-bound 95% confidence limit of the probability of a carcinogenic response per unit daily intake of a chemical over a lifetime.

Inhalation Unit Risk ( I U R IUR I U R , expressed in ( μ g/m 3 ) − 1 (\mathbf{\mu\text{g/m}^3)^{-1}} ( μ g/m 3 ) − 1 ): The upper-bound excess lifetime cancer risk resulting from continuous lifetime exposure to an agent at a concentration of 1 μ g/m 3 1\,\mu\text{g/m}^3 1 μ g/m 3 in air.

Note

Authoritative toxicity values are published in the EPA Integrated Risk Information System (IRIS) , Provisional Peer-Reviewed Toxicity Values (PPRTVs), and Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological Profiles.

  • 2. Step 3: Exposure Assessment & Chronic Daily Intake ( C D I CDI C D I )
  • Susceptible Receptors and Route Logic

Identify receptors before selecting exposure factors. Infants and children can receive higher soil/dust dose per kilogram and have developmental vulnerability; pregnant workers or residents may present fetal-development concerns; older adults or people with cardiopulmonary disease can be more vulnerable to irritants and asphyxiants; immunocompromised people may be more susceptible to biological hazards; and workers can have high task-specific inhalation or dermal contact. Susceptibility is chemical- and endpoint-specific—connect the toxic endpoint, route, duration, and life stage. Screen ingestion, inhalation, dermal absorption, injection, and transplacental or lactational pathways only where a source and transport mechanism make them plausible.

Exposure Assessment quantifies the magnitude, frequency, duration, and pathways of human contact with COPCs across current and reasonably foreseeable future land uses (Residential, Commercial/Industrial, Construction Worker, Recreational). +-----------------------------------------------------------------------------+

  • | COMPLETE EXPOSURE PATHWAY (5 CONCEPTUAL ELEMENTS) |
  • | |
  • | [1. Contaminant Source] (e.g., Leaking Underground Solvent Tank) |
  • | | |
  • | v |
  • | [2. Release Mechanism] (e.g., Leaching to Groundwater) |
  • | | |
  • | v |
  • | [3. Environmental Medium] (e.g., Saturated Sand Aquifer) |
  • | | |
  • | v |
  • | [4. Exposure Point & Route] (e.g., Potable Tap Water / Ingestion & Inhal)|
  • | | |
  • | v |
  • | [5. Receptor Population] (e.g., On-Site Residential Occupants) |
  • +-----------------------------------------------------------------------------+
  • The Chronic Daily Intake ( C D I CDI C D I ) Equation

Chemical intake received via ingestion or dermal contact is calculated as the Chronic Daily Intake ( C D I CDI C D I ) (also termed Average Daily Dose, A D D ADD A DD ), expressed in mg/kg-day \mathbf{\text{mg/kg-day}} mg/kg-day : C D I = C ⋅ I R ⋅ E F ⋅ E D B W ⋅ A T CDI = \frac{C \cdot IR \cdot EF \cdot ED}{BW \cdot AT} C D I = B W ⋅ A T C ⋅ I R ⋅ EF ⋅ E D ​

Where:

C C C = Chemical concentration in exposure medium (e.g., mg/L \text{mg/L} mg/L for water, mg/kg \text{mg/kg} mg/kg for soil; typically evaluated as the 95% Upper Confidence Limit of the arithmetic mean, 95% UCL )

I R IR I R = Intake / Ingestion Rate ( 2.0 L/day 2.0\,\text{L/day} 2.0 L/day drinking water for adults; 100 mg/day 100\,\text{mg/day} 100 mg/day soil for adults, 200 mg/day 200\,\text{mg/day} 200 mg/day soil for young children; 20 m 3 / day 20\,\text{m}^3/\text{day} 20 m 3 / day inhalation)

E F EF EF = Exposure Frequency ( days/year \text{days/year} days/year ; e.g., 350 days/yr 350\,\text{days/yr} 350 days/yr for residential, 250 days/yr 250\,\text{days/yr} 250 days/yr for commercial/industrial worker)

E D ED E D = Exposure Duration ( years \text{years} years ; e.g., 26 years 26\,\text{years} 26 years residential standard [ 6 yr child + 20 yr adult 6\,\text{yr child} + 20\,\text{yr adult} 6 yr child + 20 yr adult ], 25 years 25\,\text{years} 25 years industrial worker)

B W BW B W = Body Weight ( kg \text{kg} kg ; standard EPA values: 80 kg 80\,\text{kg} 80 kg adult, 15 kg 15\,\text{kg} 15 kg young child)

A T AT A T = Averaging Time (days):

For Non-Carcinogenic Effects: Averaged over the exact period of exposure: A T non-cancer = E D × 365 days/year AT_{\text{non-cancer}} = ED \times 365\,\text{days/year} A T non-cancer ​ = E D × 365 days/year

For Carcinogenic Effects (Lifetime Average Daily Dose - LADD): Averaged over a theoretical human lifespan of 70 years : A T cancer = 70 years × 365 days/year = 25 , 550 days AT_{\text{cancer}} = 70\,\text{years} \times 365\,\text{days/year} = \mathbf{25,550\,\text{days}} A T cancer ​ = 70 years × 365 days/year = 25 , 550 days

3. Step 4: Quantitative Risk Characterization Calculations

Risk Characterization integrates dose-response toxicity values with exposure intake estimates to generate quantitative numerical risk metrics.

1. Non-Carcinogenic Risk: Hazard Quotient ( H Q HQ H Q ) and Hazard Index ( H I HI H I )

Non-carcinogenic risk is quantified by dividing the calculated chemical intake by the compound's Reference Dose: H Q = C D I R f D \mathbf{HQ = \frac{CDI}{RfD}} HQ = RfD CDI ​

For inhalation exposures: H Q = C air R f C HQ = \frac{C_{\text{air}}}{RfC} H Q = R f C C air ​ ​

To evaluate multiple chemicals across an exposure pathway, individual Hazard Quotients are summed to calculate the Hazard Index ( H I HI H I ) : H I = ∑ i = 1 n H Q i = H Q 1 + H Q 2 + ⋯ + H Q n \mathbf{HI = \sum_{i=1}^{n} HQ_i = HQ_1 + HQ_2 + \dots + HQ_n} HI = i = 1 ∑ n ​ H Q i ​ = H Q 1 ​ + H Q 2 ​ + ⋯ + H Q n ​

Important

Non-Cancer Regulatory Benchmarks:

If H Q ≤ 1.0 \mathbf{HQ \le 1.0} HQ ≤ 1.0 and H I ≤ 1.0 \mathbf{HI \le 1.0} HI ≤ 1.0 : the screening calculation does not indicate that the reference level is exceeded; uncertainty and exposure-pathway completeness still matter.

If H Q > 1.0 \mathbf{HQ > 1.0} HQ > 1.0 or H I > 1.0 \mathbf{HI > 1.0} HI > 1.0 : the reference level is exceeded and adverse effects cannot be ruled out. The assessor refines exposure assumptions and segregates HQs by target organ / toxicological mechanism where appropriate. An HQ or HI above 1 is a risk-management concern, not proof that effects will occur or an automatic remediation mandate.

2. Carcinogenic Risk: Excess Lifetime Cancer Risk ( E L C R ELCR E L CR )

Carcinogenic risk represents the incremental probability that an individual will develop cancer over a lifetime as a direct result of chemical exposure: Risk (ELCR) = C D I × C S F \mathbf{\text{Risk (ELCR)} = CDI \times CSF} Risk (ELCR) = CDI × CSF

For multiple carcinogens across multiple exposure routes, risks are summed: Total Cancer Risk = ∑ Risk i = ∑ ( C D I i × C S F i ) \text{Total Cancer Risk} = \sum \text{Risk}_i = \sum (CDI_i \times CSF_i) Total Cancer Risk = ∑ Risk i ​ = ∑ ( C D I i ​ × CS F i ​ )

Important

EPA Superfund Target Cancer Risk Range (40 CFR § 300.430):

Target Risk Range: Under the NCP, EPA generally uses 10 − 6 to 10 − 4 \mathbf{10^{-6}\text{ to }10^{-4}} 1 0 − 6 to 1 0 − 4 cumulative excess lifetime cancer risk as the risk-management range for Superfund remedies. A value inside the range does not by itself mean no action is needed; site context, uncertainty, exposure, ARARs, and remedy-selection factors still apply.

Point of Departure: 10 − 6 \mathbf{10^{-6}} 1 0 − 6 (1 in 1,000,000) is EPA's point of departure for determining remediation goals for carcinogens under 40 CFR § 300.430(e)(2)(i)(A)(2); it is not a separate statutory bright-line standard.

Above 10 − 4 10^{-4} 1 0 − 4 : Risk above the upper end generally warrants further evaluation and risk management, but the NCP remedy decision is not reduced to an automatic engineering-control mandate. +-----------------------------------------------------------------------------+

  • | WORKED EXAMPLE: NON-CANCER (HQ) & CANCER RISK (ELCR) |
  • | |
  • | Scenario: Residential adult drinking groundwater contaminated with: |
  • | - Arsenic: C = 0.020 mg/L | RfD = 0.0003 mg/kg-day | CSF = 1.5 (mg/kg-d)^-1|
  • | - Toluene: C = 1.200 mg/L | RfD = 0.0800 mg/kg-day | Non-Carcinogen |
  • | - Adult Intake: IR = 2.0 L/day, EF = 350 days/yr, ED = 26 yr, BW = 80 kg |
  • | |
  • | Step 1: Calculate Non-Carcinogenic CDI (AT = 26 yr * 365 = 9,490 days) |
  • | CDI_factor = (2.0 L/d * 350 d/yr * 26 yr) / (80 kg * 9,490 d) |
  • | CDI_factor = 18,200 / 759,200 = 0.02397 L/kg-day |
  • | |
  • | CDI_arsenic = 0.020 mg/L * 0.02397 L/kg-day = 0.000479 mg/kg-day |
  • | CDI_toluene = 1.200 mg/L * 0.02397 L/kg-day = 0.02877 mg/kg-day |
  • | |
  • | Step 2: Calculate Hazard Quotients & Hazard Index |
  • | HQ_arsenic = 0.000479 / 0.0003 = 1.60 |
  • | HQ_toluene = 0.02877 / 0.0800 = 0.36 |
  • | HI_total = 1.60 + 0.36 = 1.96 |
  • | Finding: HI > 1.0 (driven by arsenic HQ = 1.60) -> refine/evaluate risk |
  • | |
  • | Step 3: Calculate Carcinogenic Intake for Arsenic (AT = 25,550 days) |
  • | LADD_arsenic = (0.020 mg/L * 2.0 L/d * 350 d/yr * 26 yr) / |
  • | (80 kg * 25,550 days) |
  • | LADD_arsenic = 364 / 2,044,000 = 1.781 * 10^-4 mg/kg-day |
  • | |
  • | Step 4: Calculate Excess Lifetime Cancer Risk (ELCR) |
  • | ELCR = LADD * CSF = (1.781 * 10^-4 mg/kg-day) * 1.5 (mg/kg-day)^-1 |
  • | ELCR = 2.67 * 10^-4 (approx 2.7 in 10,000) |
  • | Finding: ELCR exceeds the 10^-4 upper threshold -> Action Required! |
  • +-----------------------------------------------------------------------------+
  • 4. Ecological Risk Assessment (ERA) Framework (EPA ERAGS)

While human health risk assessment focuses on protecting individual humans, Ecological Risk Assessment (ERA) evaluates adverse chemical impacts on populations, ecological communities, and ecosystem structure/function . +-----------------------------------------------------------------------------+

  • | EPA 8-STEP ECOLOGICAL RISK ASSESSMENT (ERAGS) |
  • | |
  • | [TIER 1: SCREENING-LEVEL ECOLOGICAL RISK ASSESSMENT (SLERA)] |
  • | - Step 1: Screening-Level Problem Formulation & Environmental Setting |
  • | - Step 2: Screening-Level Exposure Estimate & Risk Calculation (EHQ) |
  • | * EHQ = EEC / TRV (If EHQ <= 1.0, Stop; If EHQ > 1.0, Proceed) |
  • | | |
  • | v |
  • | [TIER 2: BASELINE ECOLOGICAL RISK ASSESSMENT (BERA)] |
  • | - Step 3: BERA Problem Formulation & Conceptual Model |
  • | * Define Assessment Endpoints vs. Measurement Endpoints |
  • | - Step 4: Study Design and Data Quality Objectives |
  • | - Step 5: Field Verification of Sampling Design |
  • | - Step 6: Site Investigation & Laboratory Ecotoxicity Bioassays |
  • | - Step 7: Risk Characterization (Food-Web Bioaccumulation Modeling) |
  • | - Step 8: Risk Management & Remedial Target Selection |
  • +-----------------------------------------------------------------------------+
  • Screening-Level ERA (SLERA - Steps 1 & 2)

Calculates conservative Ecological Hazard Quotients ( E H Q EHQ E H Q or H Q eco HQ_{\text{eco}} H Q eco ​ ) : E H Q = E E C T R V EHQ = \frac{EEC}{TRV} E H Q = TR V EEC ​ where E E C EEC EEC is the Expected Environmental Concentration (maximum detected environmental concentration) and T R V TRV TR V is the Toxicity Reference Value (conservative ecotoxicity benchmark, e.g., EPA Region 4 ecological screening values, NOAA Screening Quick Reference Tables / SQiRTs, EPA Ambient Water Quality Criteria / AWQC).

If E H Q ≤ 1.0 EHQ \le 1.0 E H Q ≤ 1.0 , the screening comparison generally does not identify a benchmark exceedance; confirm pathway completeness and uncertainty before concluding the screen.

If E H Q > 1.0 EHQ > 1.0 E H Q > 1.0 , ecological risk cannot be ruled out; project transitions into a full Baseline Ecological Risk Assessment (BERA) .

Baseline ERA (BERA) Core Concepts:

Assessment Endpoints: Explicit operational expressions of the actual environmental value to be protected (e.g., "Maintenance of self-sustaining, reproducing populations of native salmonid fish in the river" or "Protection of soil invertebrate communities from toxic mortality" ).

Measurement Endpoints: Measurable ecological characteristics, field surveys, or laboratory test responses used to infer changes in the assessment endpoint (e.g., "Laboratory 10-day sediment toxicity bioassay survival rate of Hyalella azteca" or "Fish tissue PCB concentration measurements" ).

Food-Web Bioaccumulation & Biomagnification Modeling: Quantifies the uptake and trophic transfer of hydrophobic contaminants ( log ⁡ K o w > 3.0 \log K_{ow} > 3.0 lo g K o w ​ > 3.0 ) through ecological food chains using:

Bioconcentration Factor ( B C F BCF BCF ): Direct chemical uptake from water to organism: B C F = C tissue C water BCF = \frac{C_{\text{tissue}}}{C_{\text{water}}} BCF = C water ​ C tissue ​ ​ .

Bioaccumulation Factor ( B A F BAF B A F ): Chemical uptake from all environmental sources (water, sediment, and dietary food ingestion).

Biota-Sediment Accumulation Factor ( B S A F BSAF BS A F ): Normalizes tissue lipid content to sediment organic carbon: B S A F = C tissue / f lipid C sediment / f o c BSAF = \frac{C_{\text{tissue}} / f_{\text{lipid}}}{C_{\text{sediment}} / f_{oc}} BS A F = C sediment ​ / f oc ​ C tissue ​ / f lipid ​ ​ .

Loading diagram... EPA Human Health and Ecological Risk Assessment Decision Architecture